New hope for kids with tough leukemia: transplant plus CAR t cells
NCT ID NCT07257419
First seen Jan 05, 2026 · Last updated Jun 13, 2026 · Updated 25 times
Summary
This study tests a new way to do a stem cell transplant for children with a hard-to-treat type of leukemia (ALL). It uses special immune cells (CAR T cells) from a partially matched family donor to try to kill any remaining cancer cells after the transplant. The goal is to see if this combination is safe and works better than standard transplant. About 70 children up to age 21 with high-risk leukemia will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.